Yunnan Baiyao Group Co.Ltd(000538)
Prior approval opinions of independent directors
In accordance with the company law of the people’s Republic of China, the securities law of the people’s Republic of China, the guiding opinions on the establishment of independent director system in listed companies, the stock listing rules of Shenzhen Stock Exchange and the articles of association, as independent directors of Yunnan Baiyao Group Co.Ltd(000538) (hereinafter referred to as “the company”), on the basis of carefully reviewing relevant materials and listening to the report of the management, The company has carefully reviewed the proposal on estimated daily connected transactions in 2022 and issued the following prior approval opinions:
1. The affiliated companies of Kunming stock exchange shall be listed in accordance with the relevant rules of Jiangsu Hongyun hospital Co., Ltd;
2. The company has reasonably estimated the amount of daily connected transactions in 2022, which meets the needs of the company’s normal business activities and is conducive to the development of the company’s business;
3. This connected transaction complies with the provisions of relevant laws and regulations, follows the principle of market pricing, and does not damage the interests of the company, other non connected shareholders and the majority of minority shareholders.
Based on the above situation, we agree to submit the proposal on estimated daily connected transactions in 2022 to the fourth meeting of the ninth board of directors in 2022 for deliberation.
Independent directors: Yin Xiaobing, Dai Yang, Zhang Yongliang, Liu Guoen March 24, 2022
